In Journal of magnetic resonance imaging : JMRI
BACKGROUND : Determination of H3 K27M mutation in diffuse midline glioma (DMG) is key for prognostic assessment and stratifying patient subgroups for clinical trials. MRI can noninvasively depict morphological and metabolic characteristics of H3 K27M mutant DMG.
PURPOSE : This study aimed to develop a deep learning (DL) approach to noninvasively predict H3 K27M mutation in DMG using T2-weighted images.
STUDY TYPE : Retrospective and prospective.
POPULATION : For diffuse midline brain gliomas, 341 patients from Center-1 (27 ± 19 years, 184 males), 42 patients from Center-2 (33 ± 19 years, 27 males) and 35 patients (37 ± 18 years, 24 males). For diffuse spinal cord gliomas, 133 patients from Center-1 (30 ± 15 years, 80 males).
FIELD STRENGTH/SEQUENCE : 5T and 3T, T2-weighted turbo spin echo imaging.
ASSESSMENT : Conventional radiological features were independently reviewed by two neuroradiologists. H3 K27M status was determined by histopathological examination. The Dice coefficient was used to evaluate segmentation performance. Classification performance was evaluated using accuracy, sensitivity, specificity, and area under the curve.
STATISTICAL TESTS : Pearson's Chi-squared test, Fisher's exact test, two-sample Student's t-test and Mann-Whitney U test. A two-sided P value <0.05 was considered statistically significant.
RESULTS : In the testing cohort, Dice coefficients of tumor segmentation using DL were 0.87 for diffuse midline brain and 0.81 for spinal cord gliomas. In the internal prospective testing dataset, the predictive accuracies, sensitivities, and specificities of H3 K27M mutation status were 92.1%, 98.2%, 82.9% in diffuse midline brain gliomas and 85.4%, 88.9%, 82.6% in spinal cord gliomas. Furthermore, this study showed that the performance generalizes to external institutions, with predictive accuracies of 85.7%-90.5%, sensitivities of 90.9%-96.0%, and specificities of 82.4%-83.3%.
DATA CONCLUSION : In this study, an automatic DL framework was developed and validated for accurately predicting H3 K27M mutation using T2-weighted images, which could contribute to the noninvasive determination of H3 K27M status for clinical decision-making.
EVIDENCE LEVEL : 2 Technical Efficacy: Stage 2.
Li Junjie, Zhang Peng, Qu Liying, Sun Ting, Duan Yunyun, Wu Minghao, Weng Jinyuan, Li Zhaohui, Gong Xiaodong, Liu Xing, Wang Yongzhi, Jia Wenqing, Su Xiaorui, Yue Qiang, Li Jianrui, Zhang Zhiqiang, Barkhof Frederik, Huang Raymond Y, Chang Ken, Sair Haris, Ye Chuyang, Zhang Liwei, Zhuo Zhizheng, Liu Yaou
2023-Jan-24
H3 K27M mutation, deep learning, diffuse midline glioma, magnetic resonance imaging
